Created at Source Raw Value Validated value
Dec. 13, 2020, 12:31 a.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Ibrutinib;Quality-of-Life Assessment", "treatment_type": "Drug;Other", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Ibrutinib;Quality-of-Life Assessment", "treatment_type": "Drug;Other", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Quality-of-Life Assessment", "treatment_type": "Other", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "Ibrutinib PO daily or stop ibrutinib per provider's discretion", "treatment_id": 617, "treatment_name": "Ibrutinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Ibrutinib PO daily in the absence of disease progression or unacceptable toxicity.", "treatment_id": 617, "treatment_name": "Ibrutinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]